Citation

Eshuis EJ, Magnin KM, Stokkers PC, Bemelman WA, Bartelsman J. J. Crohns Colitis 2010; 4(5): 591-593.

Affiliation

Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands; Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.

Copyright

(Copyright © 2010, Elsevier Publishing)

DOI

10.1016/j.crohns.2010.04.001

PMID

21122565

Abstract

In the summary of product characteristics of infliximab (IFX), psychiatric side effects are reported to be rare, and in literature only limited data exist. This report presents a case of a patient with ulcerative colitis who developed a depression with psychotic symptoms during IFX therapy and made a suicide attempt 4months after the initiation of therapy. Although the time between start of IFX therapy and onset of symptoms could suggest a correlation, this, of course, does not prove that IFX was the causative factor for his depression and suicide attempt.

Language: en